BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, CXCL2, Response to oxidative stress, Hepatitis, Liver, Rosiglitazone)
Bookmark Forward

Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.

Sarah N Lauder, Bart Vanhaesebroeck, Awen Gallimore

British journal of cancer 2021 Aug


filter terms:
  • antigens cd (2)
  • antitumor (1)
  • class i phosphatidylinositol 3- kinases (2)
  • gene (1)
  • gene protein (1)
  • humans (1)
  • LAG3 (2)
  • lymphocyte (2)
  • mice (2)
  • pik3cd protein, human (1)
  • protein human (1)
  • tumour (1)
  • xenograft (1)
    • Sizes of these terms reflect their relevance to your search.

    Emerging studies have demonstrated the potential of PI3Kδ blockade as an immunotherapy for solid tumours. In pre-clinical models, we recently demonstrated that anti-LAG3 immune checkpoint blockade vastly potentiated PI3Kδ-based immunotherapy, enabling successful tumour control in all treated mice. © 2021. The Author(s).

    Citation

    Sarah N Lauder, Bart Vanhaesebroeck, Awen Gallimore. Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach. British journal of cancer. 2021 Aug;125(4):467-469

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33824480

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.